trial

Electronic Cigarettes in Smokers With Mental Illness

NCTId NCT02212041
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by King's College London
Primary completion 2017-05-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2014-09-24
Primary completion
2017-05-02
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
disposable electronic cigarettes

Sponsors

King's College LondonLead Sponsor

Investigators

5
Rocio Perez-Iglesias, MD, PhDPrincipal Investigator
Ann McNeill, BSc, PhD, ProfPrincipal Investigator
Lynne Dawkins, BSc, PhDPrincipal Investigator
John Moxham, MD, PhD, ProfPrincipal Investigator
Philip McGuire, MD, PhD, ProfPrincipal Investigator

Sites

1 total
London, United Kingdom

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2017-05-02
Status
COMPLETED
relationships
The graph out of here
drug
disposable electronic cigarettes
drug
lead_sponsor
King's College London
company
indication
Smoking
indication
Bipolar Disorder
indication
Schizophreniform Disorder
indication
investigator
Rocio Perez-Iglesias, MD, PhD
person
Ann McNeill, BSc, PhD, Prof
person
Lynne Dawkins, BSc, PhD
person
John Moxham, MD, PhD, Prof
person